A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?
2024

Global Guidelines for Antimicrobial Stability Testing in Outpatient Therapy

publication Evidence: moderate

Author Information

Author(s): Naicker Saiyuri, Roberts Jason A, Cheng Vesa, Parker Suzanne L, Seaton R Andrew, Gilchrist Mark, Sime Fekade B

Primary Institution: The University of Queensland Centre for Clinical Research

Hypothesis

Is it time for global harmonization of testing frameworks for antimicrobial stability in outpatient parenteral antimicrobial therapy (OPAT) programmes?

Conclusion

A global OPAT-specific regulatory framework for antimicrobial stability testing is needed to ensure consistency and improve patient access to effective treatments.

Supporting Evidence

  • Antimicrobial stability is crucial for outpatient treatment planning.
  • Current guidelines for stability testing vary significantly by region.
  • Only the UK NHS has provided specific guidance for OPAT stability testing.

Takeaway

This study says we need to make sure that the rules for checking how long medicines stay good are the same everywhere, especially for patients getting treatment at home.

Methodology

The review discusses existing guidelines and regulations for antimicrobial stability testing across different regions and highlights the need for harmonization.

Limitations

The review is based on existing literature and guidelines, which may vary in quality and applicability across different regions.

Digital Object Identifier (DOI)

10.1093/jacamr/dlae186

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication